SCHEMBL20169248

SCHEMBL20169248

COC(=O)CNc1ccc(F)cc1C

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.58
MAPT P10636 8/20 0.58
KMT2A Q03164 5/20 0.56
MEN1 O00255 4/20 0.46
TDP1 Q9NUW8 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 2/20 0.46
POLB P06746 1/20 0.46
MAPK1 P28482 1/20 0.44
PIK3CA P42336 3/20 0.43
VDR P11473 1/20 0.42
PIK3CG P48736 2/20 0.42
TRPA1 O75762 1/20 0.42
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4017286 0.88 MAPT (0.56) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL9779937 0.87 NPC1 (0.50) ALDH1A1MAPTTDP1SMN1; SMN2LMNA
SCHEMBL16887793 0.83 ALDH1A1 (0.61) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL3841711 0.78 LMNA (0.55) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL20941779 0.77 ALDH1A1 (0.69) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL20941589 0.77 MAPT (0.61) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL9779960 0.76 MAPT (0.53) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL20941597 0.76 ALDH1A1 (0.76) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL20942397 0.76 ALDH1A1 (0.60) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL27626623 0.76 MCL1 (0.56) ALDH1A1MAPTKMT2AMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10766882-B2 1,2-naphthoquinone based derivative and method of preparing the same YUNGJIN PHARM CO., LTD. (KR) 2020-09-08 US disclosed
US-9975883-B2 1,2-naphthoquinone based derivative and method of preparing the same YUNGJIN PHARM. CO., LTD. (KR) 2018-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10766882-B2 1,2-naphthoquinone based derivative and method of preparing the same CYP2S1, GYS2, SLC5A1 ALDH1A1 688/4885MAPT 141/4885KMT2A 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.